Decibel Therapeutics Shares Soar on Acquisition by Regeneron Pharmaceuticals

Like
Comment
Favorite

Decibel Therapeutics Shares Soar on Acquisition by Regeneron Pharmaceuticals

Investopedia2023-08-10

Key TakeawaysRegeneron Pharmaceuticals agreed to buy Decibel Therapeutics for up to $213 million.Decibel shareholders will get $4 per share at the close of the deal, with a possible 3.50 per share ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2358750282?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-08-10 17:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2358750282","market":"us","top_or_hot":-1,"title":"Decibel Therapeutics Shares Soar on Acquisition by Regeneron Pharmaceuticals","media":"Investopedia","content":"<div>\n<p>Key TakeawaysRegeneron Pharmaceuticals agreed to buy Decibel Therapeutics for up to $213 million.Decibel shareholders will get $4 per share at the close of the deal, with a possible 3.50 per share ...</p>\n\n<a href=\"https://www.investopedia.com/regeneron-pharmaceuticals-agrees-to-buy-decibel-therapeutics-7574434?utm_campaign=quote-yahoo&utm_source=yahoo&utm_medium=referral&yptr=yahoo\">Source Link</a>\n\n</div>\n","source":"yahoofinance_sg","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Decibel Therapeutics Shares Soar on Acquisition by Regeneron Pharmaceuticals</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDecibel Therapeutics Shares Soar on Acquisition by Regeneron Pharmaceuticals\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-08-10 17:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investopedia.com/regeneron-pharmaceuticals-agrees-to-buy-decibel-therapeutics-7574434?utm_campaign=quote-yahoo&utm_source=yahoo&utm_medium=referral&yptr=yahoo><strong>Investopedia</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key TakeawaysRegeneron Pharmaceuticals agreed to buy Decibel Therapeutics for up to $213 million.Decibel shareholders will get $4 per share at the close of the deal, with a possible 3.50 per share ...</p>\n\n<a href=\"https://www.investopedia.com/regeneron-pharmaceuticals-agrees-to-buy-decibel-therapeutics-7574434?utm_campaign=quote-yahoo&utm_source=yahoo&utm_medium=referral&yptr=yahoo\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DBTX","symbol_name":"Decibel Therapeutics, Inc.","start_time":0,"source_url":"https://www.investopedia.com/regeneron-pharmaceuticals-agrees-to-buy-decibel-therapeutics-7574434?utm_campaign=quote-yahoo&utm_source=yahoo&utm_medium=referral&yptr=yahoo","article_id":"2358750282","we_media_id":null,"thumbnails":[],"rights":{"source":"yahoofinance_sg","url":"https://www.investopedia.com/regeneron-pharmaceuticals-agrees-to-buy-decibel-therapeutics-7574434?utm_campaign=quote-yahoo&utm_source=yahoo&utm_medium=referral&yptr=yahoo","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2358750282","pubTimestamp":1691659619,"sourceInfo":{"source_id":"yahoofinance_sg","name":"Yahoo Finance"},"weMediaInfo":null,"summary":"Investing. Stocks. Bonds. ETFs. Options and Derivatives. Commodities. Trading. FinTech and Automated Investing. Brokers. Fundamental Analysis. Technical Analysis. Markets. View All. Simulator. Login / Portfolio. Trade. My Games. Leaderboard. Economy. Government Policy. Monetary Policy. Fiscal Policy. View All. Personal Finance. Financial Literacy. Retirement. Budgeting. Saving. Personal Loans. Taxes. Home Ownership. View All. News. Markets. Companies. Earnings. Economy. Crypto. Personal Finance. Government. View All. Reviews. Best Online Brokers. Best Life Insurance Companies. Best CD Rates. Best Savings Accounts. Best Personal Loans. Best Credit Repair Companies. Best Mortgage Rates. Best Auto Loan Rates. Best Credit Cards. View All. Academy. Investing for Beginners. Trading for Beginners. Become a Day Trader. Technical Analysis. All Investing Courses. All Trading Courses. View All. Trade. Please fill out this field.Please fill out this field.Investing. Investing. Stocks. Bonds. ETFs.","collect":0,"end_time":0,"defaultTopTitle":"investopedia.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"DBTX":"Decibel Therapeutics, Inc.","REGN":"再生元制药公司"},"translate_title":"再生元制药收购分贝治疗公司股价飙升","themeId":"c5bbfdf5f7964880af97c1d6f417052c","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DBTX":1,"REGN":1},"content_text":"Key TakeawaysRegeneron Pharmaceuticals agreed to buy Decibel Therapeutics for up to $213 million.Decibel shareholders will get $4 per share at the close of the deal, with a possible 3.50 per share later.Decibel's top drug candidate treats certain hearing loss in children.Shares of Decibel Therapeutics  skyrocketed more than 80% on Wednesday after Regeneron Pharmaceuticals  agreed to buy the biotech firm for up to $213 million to expand its gene therapy pipeline. Regeneron Pharmaceuticals shares rose 1% as well. Regeneron said Decibel investors will receive $4 per share at the close of the transaction, with the potential of an additional $3.50 per share if certain clinical development and regulatory milestones are reached for its top drug candidate, DB-OTO, a gene therapy that treats hearing loss in children. At the maximum, the deal would be a 169% premium to Decibel’s closing price yesterday.The two companies were already working together after signing a collaboration agreement in 2017, which was extended in 2021. They are developing three gene therapy programs aimed at different forms of congenital, monogenic hearing loss.Decibel CEO Laurence Reid explained the board felt with Regeneron’s “expertise and resources,” Decibel’s pipeline can be optimally developed, and the merger was the best way to maximize shareholder value and ultimately benefit patients.Regeneron indicated it expects the transaction to close in the current quarter. Shares of Decibel Therapeutics hit an 11-month high following the news.","kind":"highlight","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}